Some studies have shown that CTMP binds to AKT and negatively regulates its activity in many diseases, including lung cancer, colorectal cancer, pancreatic cancer, liver cancer, diabetes, cardiovascular disease, myogenic differentiation, and amyotrophic lateral sclerosis. Here, THEM4 is linked to lung cancer.